IRIS
TRIESTE, LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.406
EU - Europa 5.185
AS - Asia 4.370
SA - Sud America 880
AF - Africa 119
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 20
Totale 18.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.089
SG - Singapore 1.657
IT - Italia 1.491
RU - Federazione Russa 1.195
CN - Cina 1.094
GB - Regno Unito 734
BR - Brasile 677
VN - Vietnam 624
DE - Germania 436
UA - Ucraina 286
HK - Hong Kong 233
CA - Canada 226
FR - Francia 187
KR - Corea 161
DK - Danimarca 147
IN - India 136
NL - Olanda 108
SE - Svezia 106
FI - Finlandia 95
AR - Argentina 78
IE - Irlanda 74
PL - Polonia 66
BD - Bangladesh 63
MX - Messico 62
ES - Italia 60
JP - Giappone 58
TR - Turchia 56
ZA - Sudafrica 46
ID - Indonesia 42
EC - Ecuador 41
AU - Australia 36
BE - Belgio 34
IQ - Iraq 32
PH - Filippine 31
AT - Austria 30
PK - Pakistan 30
CO - Colombia 25
PT - Portogallo 22
MY - Malesia 21
CH - Svizzera 20
EU - Europa 20
IL - Israele 19
TW - Taiwan 19
LT - Lituania 15
TN - Tunisia 15
MA - Marocco 14
PY - Paraguay 14
RO - Romania 14
SA - Arabia Saudita 12
UZ - Uzbekistan 12
VE - Venezuela 12
CL - Cile 11
JO - Giordania 11
PE - Perù 11
SK - Slovacchia (Repubblica Slovacca) 10
KE - Kenya 8
AZ - Azerbaigian 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
EG - Egitto 6
GR - Grecia 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
IR - Iran 5
JM - Giamaica 5
LU - Lussemburgo 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
KZ - Kazakistan 4
SI - Slovenia 4
UY - Uruguay 4
AO - Angola 3
BO - Bolivia 3
DM - Dominica 3
HN - Honduras 3
HU - Ungheria 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SR - Suriname 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
Totale 17.998
Salva come PNG Salva come JPEG
Città #
Dallas 1.858
Singapore 920
Ashburn 505
San Jose 472
Beijing 422
Chandler 375
Woodbridge 342
Southend 341
Houston 268
Pisa 218
Hong Kong 217
Moscow 185
San Mateo 175
Ann Arbor 170
Ho Chi Minh City 169
The Dalles 156
Los Angeles 146
Jacksonville 142
Fairfield 123
Hanoi 119
New York 119
Dearborn 105
Seattle 100
Daejeon 97
Rome 96
Cambridge 90
Wilmington 89
Boardman 88
Falls Church 87
Milan 85
São Paulo 80
Hefei 77
Beauharnois 70
Santa Clara 70
Lauterbourg 69
Dublin 67
Dong Ket 65
Seoul 62
Stevenage 61
Portsmouth 59
Warsaw 58
Lawrence 55
Orem 54
Brooklyn 49
Fremont 49
Montreal 49
Denver 46
Florence 44
Tokyo 43
Buffalo 42
Chennai 42
London 42
Munich 41
Stockholm 38
Atlanta 37
Salerno 37
Council Bluffs 35
Helsinki 33
Bologna 31
Serra 31
Johannesburg 30
Poplar 30
Mexico City 29
Haiphong 28
Paris 27
Phoenix 27
Frankfurt am Main 26
Buti 25
Montréal 25
Amsterdam 24
Chicago 24
Redwood City 23
Ankara 22
Old Bridge 21
Genoa 20
Lucca 20
Nuremberg 20
Boston 19
Ottawa 19
Rio de Janeiro 17
San Francisco 17
Toronto 17
Da Nang 16
Dhaka 15
Guayaquil 15
Livorno 15
Mumbai 15
Querétaro 15
Quito 15
Trento 15
Vienna 15
Hamburg 14
Istanbul 14
Manchester 14
Tel Aviv 14
Charlotte 12
Naples 12
Taipei 12
Turku 12
Xi'an 12
Totale 10.577
Salva come PNG Salva come JPEG
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 751
On Robots and Insurance 570
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 484
The Effect of using Serifs in Brand Names on Luxury Perception 460
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 397
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 363
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 353
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 328
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 319
A systematic literature review of the economic impact of ankylosing spondylitis 305
How colour saturation accelerates purchase behaviour, and influences food choice: 300
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 293
Is EEG Suitable for Marketing Research? A Systematic Review 292
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 286
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 285
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 276
Natural and man-made disasters: challenges and international perspectives for insurance 275
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 273
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 271
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 270
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 268
Assessing the value of the use of diagnostic technology: trade offs for GPs 265
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 260
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 254
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 254
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 251
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 244
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 240
Columbus' egg and the engineer's effect in forecasting solutions adoption 239
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 239
Health information technologies in systemic lupus erythematosus: focus on patient assessment 239
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 236
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 235
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 232
Management and Treatment of Type 1 And 2 Diabetes: State of Art 231
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 231
Systemic vasculitis: how little we know about their societal and economic burden 229
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 226
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 225
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 224
Raiders of Lost Value 220
Consideration on the Accuracy of Watch for Physical Activity Tracker 220
The definition of a new organizational, technology-based, integrated home care model 218
The economic impact of gout: a systematic literature review 210
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 210
Food literacy and food purchase behaviour 207
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 205
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 203
Natura e ruolo degli indicatori nella logistica farmaceutica 198
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 198
Razionale e strumenti della valutazione economica in sanità 197
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 183
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 182
The nature, causes, and effects of skepticism on technology diffusion 182
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 178
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 177
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 176
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 172
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 169
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 166
Finanziamenti pubblici 165
Le start up 160
Analysis and Synthesis in Information Processing and Knowledge Creation 157
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 157
Strumenti per favorire gli investimenti e la competitività delle imprese 157
Valutazione dei risultati di una gara 157
EYE ON PACK. Visual search strategies in food choice 156
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 147
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 141
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 141
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 139
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 129
Industria 4.0 e Digitalizzazione 117
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 107
Managing customization, brand consistency, and identity dynamic trade-offs: opportunities and chaos 70
null 63
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 61
Nonlinear trade-offs in customer acquisition and retention 55
null 13
Totale 18.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021297 0 0 0 0 0 0 0 0 0 0 133 164
2021/2022745 23 141 29 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20268.627 504 1.192 1.623 1.203 1.001 594 1.003 405 503 560 39 0
Totale 18.136